Cranberry supplements market seen topping $443M by 2033

By AI, Created 11:30 AM UTC, May 21, 2026, /AGP/ – The global cranberry supplements market is projected to grow from $311.1 million in 2026 to $443.6 million by 2033 as UTI prevention, clinical support, and e-commerce expand demand. North America leads now, while Asia Pacific is poised for the fastest growth as manufacturers push new formats like gummies and combination products.

Why it matters: - Cranberry supplements are gaining traction as a non-antibiotic option for urinary tract health at a time when antimicrobial resistance and preventive care are reshaping consumer behavior. - The category’s growth could influence product development across dietary supplements, pharmacy shelves, and online wellness channels. - Women and older adults remain the core demand base because UTI prevention is a clear, recurring use case.

What happened: - The global cranberry supplements market is projected to reach $311.1 million in 2026 and $443.6 million by 2033. - The forecast implies a 5.2% compound annual growth rate from 2026 to 2033. - The market is expanding on the back of higher UTI prevalence, rising health awareness, and broader distribution through retail and e-commerce. - A sample report is available here.

The details: - UTIs affect about 150 million people annually worldwide. - About 50% to 60% of women experience at least one UTI in their lifetime. - Women ages 18 to 49 face annual UTI incidence rates of 10% to 15%. - Systematic reviews in journals including JAMA and the Cochrane Database found cranberry products containing proanthocyanidins can reduce UTI risk by 26% to 32% in women with recurrent infections. - The FDA authorized qualified health claims in 2020 for cranberry supplements containing 500 mg per day of whole cranberry fruit dietary supplements, with label disclaimers. - North America held 38% of the market in 2025. - Asia Pacific is expected to be the fastest-growing region by 2033. - Pharmacies accounted for 42% of revenue in 2025. - Capsules held 34% market share in 2025. - Enteric-coated and gastro-resistant formats are used to help preserve PAC stability and dosing over 3 to 12 months. - Sugar-free gummies and combination products with probiotics and D-mannose are opening a projected $2.1 billion addressable market by 2033. - Key market players include Swisse, Nature’s Bounty, AZO, Blackmores, Holland & Barrett, GNC, Jamieson, Webber Naturals, Healthy Care, TruNature, Nutra-Life, By-Health, Cystex, NOW Foods, Solgar, and Nature’s Way.

Between the lines: - Clinical evidence and FDA-backed claims are helping cranberry supplements look more credible than many wellness products in the crowded preventive-health aisle. - The market still faces uneven evidence across studies because cranberry species, extraction methods, PAC dosage, and supplement duration vary widely. - Europe remains harder to penetrate because the European Food Safety Authority has rejected most generic UTI prevention claims. - Premium positioning is also challenged by product quality variation, sugar-heavy traditional juices, and occasional adulteration concerns. - The strongest growth opportunities appear to be in convenient formats and multi-ingredient products that can justify higher price points.

What’s next: - Brands are likely to keep leaning into gummies, soft chews, and combination formulas to win younger consumers and support repeat purchases. - Asia Pacific should draw more investment as e-commerce expands and manufacturers localize products for regional health needs. - More clinical validation and regulatory support will likely shape which brands can scale beyond niche wellness positioning. - A customization request is available here.

The bottom line: - Cranberry supplements are moving from niche urinary-health products to a broader preventive-care category, with evidence, format innovation, and channel expansion driving the next phase of growth.